Prostate cancer is the second most common cancer among U. S. men and is the second leading cause of death in men. Following the demand of patients the new prostate cancer treatments such as advanced radiation therapy and less invasive surgery are growing rapidly. These treatments are attracting more people as compared to the conventional surgeries.

A recent study has found that the new technologies for the treatment of prostate cancer cost a few hundred dollars more than a conventional treatments. These technologies are rapidly taken up by the hospitals and doctors. The National Institutes of Health estimates that prostate cancer treatments cost about $12 billion each year.

The study was conducted from 2002 to 2005 on 45,000 men who were covered under the U. S. federal health insurance program for people over age 65. The research concluded that that each treatment with the advanced radiation therapy cost about $11,000 more than the 3-D conformal radiation therapy.

The lead author of the study, Dr. Paul Nguyen at the Dana-Farber Cancer Institute and Brigham and Women's Hospital, says that the new treatments have gained popularity but there is no data related to the advanced treatments, which shows that it saves more lives.